Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
12 pending office actions • 6 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days
National Cancer Center currently manages 11 pending office actions. These actions are located in the Medical Devices & Mechanical Engineering technology area. The portfolio involves 11 distinct examiners and 6 distinct art units. This distribution shows a level of technical and personnel diversity in the prosecution of the company's applications.
GARTLAND, SCOTT D is the busiest examiner, responsible for 1 pending office action. Because the number of distinct examiners is 11, which equals the number of pending actions, each examiner is reviewing only one case. This distribution requires the applicant to address 11 different examiner viewpoints across 6 different art units. The lack of concentration among examiners means that no single individual's tendencies will dominate the overall portfolio outcomes across the 6 art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (33%) |
| §103 only | 1 (8%) |
| §102 only | 3 (25%) |
| §112 only | 1 (8%) |
| Multi-statute (no §101) | 3 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GARTLAND, SCOTT D | 1 | 10.9% | +12.2% |
| BARKER, DAYTON HYUN JIN | 1 | 71.4% | +40.0% |
| MCGRATH, ERIN E | 1 | 60.1% | +28.6% |
| ROZANSKI, GRACE NMN | 1 | 60.5% | +20.7% |
| MONAHAN, MEGAN ELIZABETH | 1 | 58.0% | +14.4% |
| EKRAMI, YASAMIN | 1 | 41.6% | +46.3% |
| LIPPERT, JOHN WILLIAM | 1 | 58.2% | +40.0% |
| VAZ, JANICE EZVI | 1 | 77.0% | +18.5% |
| FAIRCHILD, AARON BENJAMIN | 1 | 79.6% | +20.2% |
| WECKER, JENNIFER | 1 | 71.0% | +36.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18583630 | ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM | FAIRCHILD, AARON BENJAMIN | 28d |
| 19098192 | METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER | GARTLAND, SCOTT D | — |
| 18852432 | BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY | ROZANSKI, GRACE NMN | — |
| 18897470 | ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM | MONAHAN, MEGAN ELIZABETH | — |
| 18793301 | NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF | LIPPERT, JOHN WILLIAM | — |
| 18637665 | IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND COMPUTER PROGRAM | VAZ, JANICE EZVI | — |
| 18566404 | BIOMARKER COMPOSITION CONTAINING ACYL CARNITINE METABOLITE FOR DIAGNOSIS OF ORAL CANCER | WECKER, JENNIFER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18583630 | ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM | FAIRCHILD, AARON BENJAMIN | 28d |
| 19098192 | METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER | GARTLAND, SCOTT D | — |
| 19049859 | ENDOSCOPE SYSTEM, CONTROL DEVICE, CONTROL METHOD, AND STORAGE MEDIUM | BARKER, DAYTON HYUN JIN | — |
| 19037342 | GRIPPING FORCEPS AND SUTURING METHOD | MCGRATH, ERIN E | — |
| 18852432 | BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY | ROZANSKI, GRACE NMN | — |
| 18897470 | ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM | MONAHAN, MEGAN ELIZABETH | — |
| 18839816 | HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT | EKRAMI, YASAMIN | — |
| 18793301 | NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF | LIPPERT, JOHN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 3795 | 2 |
| 3685 | 1 |
| 3794 | 1 |
| 2667 | 1 |
| 1651 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19098192 | METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER | GARTLAND, SCOTT D | 3685 | §101§112 | Final Rejection | — | Pending | Apr 02, 2025 |
| 19049859 | ENDOSCOPE SYSTEM, CONTROL DEVICE, CONTROL METHOD, AND STORAGE MEDIUM | BARKER, DAYTON HYUN JIN | — | §112 | Non-Final OA | — | Pending | Feb 10, 2025 |
| 19037342 | GRIPPING FORCEPS AND SUTURING METHOD | MCGRATH, ERIN E | — | §102 | Non-Final OA | — | Pending | Jan 27, 2025 |
| 18852432 | BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY | ROZANSKI, GRACE NMN | — | §103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18897470 | ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM | MONAHAN, MEGAN ELIZABETH | 3795 | §102§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18839816 | HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT | EKRAMI, YASAMIN | 3794 | §103 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18793301 | NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF | LIPPERT, JOHN WILLIAM | — | §103§112 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18637665 | IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND COMPUTER PROGRAM | VAZ, JANICE EZVI | 2667 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18583630 | ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM | FAIRCHILD, AARON BENJAMIN | 3795 | §101§102§103§112 | Final Rejection | 28d | Pending | Feb 21, 2024 |
| 18566404 | BIOMARKER COMPOSITION CONTAINING ACYL CARNITINE METABOLITE FOR DIAGNOSIS OF ORAL CANCER | WECKER, JENNIFER | — | §101§103 | Final Rejection | — | Pending | Dec 01, 2023 |
| 18250913 | APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT | ARMATO JR, DENNIS IGNATIUS | 1651 | §102 | Non-Final OA | 84d | Pending | Apr 27, 2023 |
| 17904926 | METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS | BELYAVSKYI, MICHAIL A | 1644 | §102 | Non-Final OA | — | Pending | Aug 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial